Postmenopausal Vaginal Atrophy Drugs Market

List of Tables
Table 1. Key Players of Postmenopausal Vaginal Atrophy Drugs in Global Market
Table 2. Top Postmenopausal Vaginal Atrophy Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Postmenopausal Vaginal Atrophy Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Postmenopausal Vaginal Atrophy Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Postmenopausal Vaginal Atrophy Drugs Sales by Companies, (K Units), 2017-2022
Table 6. Global Postmenopausal Vaginal Atrophy Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Postmenopausal Vaginal Atrophy Drugs Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Postmenopausal Vaginal Atrophy Drugs Product Type
Table 9. List of Global Tier 1 Postmenopausal Vaginal Atrophy Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Postmenopausal Vaginal Atrophy Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Postmenopausal Vaginal Atrophy Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Postmenopausal Vaginal Atrophy Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Postmenopausal Vaginal Atrophy Drugs Sales (K Units), 2017-2022
Table 15. By Type - Global Postmenopausal Vaginal Atrophy Drugs Sales (K Units), 2023-2028
Table 16. By Application ? Global Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Postmenopausal Vaginal Atrophy Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Postmenopausal Vaginal Atrophy Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Postmenopausal Vaginal Atrophy Drugs Sales (K Units), 2017-2022
Table 20. By Application - Global Postmenopausal Vaginal Atrophy Drugs Sales (K Units), 2023-2028
Table 21. By Region ? Global Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Postmenopausal Vaginal Atrophy Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Postmenopausal Vaginal Atrophy Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Postmenopausal Vaginal Atrophy Drugs Sales (K Units), 2017-2022
Table 25. By Region - Global Postmenopausal Vaginal Atrophy Drugs Sales (K Units), 2023-2028
Table 26. By Country - North America Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Postmenopausal Vaginal Atrophy Drugs Sales, (K Units), 2017-2022
Table 29. By Country - North America Postmenopausal Vaginal Atrophy Drugs Sales, (K Units), 2023-2028
Table 30. By Country - Europe Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Postmenopausal Vaginal Atrophy Drugs Sales, (K Units), 2017-2022
Table 33. By Country - Europe Postmenopausal Vaginal Atrophy Drugs Sales, (K Units), 2023-2028
Table 34. By Region - Asia Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Postmenopausal Vaginal Atrophy Drugs Sales, (K Units), 2017-2022
Table 37. By Region - Asia Postmenopausal Vaginal Atrophy Drugs Sales, (K Units), 2023-2028
Table 38. By Country - South America Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Postmenopausal Vaginal Atrophy Drugs Sales, (K Units), 2017-2022
Table 41. By Country - South America Postmenopausal Vaginal Atrophy Drugs Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Postmenopausal Vaginal Atrophy Drugs Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Postmenopausal Vaginal Atrophy Drugs Sales, (K Units), 2023-2028
Table 46. Actavis plc Corporate Summary
Table 47. Actavis plc Postmenopausal Vaginal Atrophy Drugs Product Offerings
Table 48. Actavis plc Postmenopausal Vaginal Atrophy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Bionovo, Inc. Corporate Summary
Table 50. Bionovo, Inc. Postmenopausal Vaginal Atrophy Drugs Product Offerings
Table 51. Bionovo, Inc. Postmenopausal Vaginal Atrophy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Endoceutics, Inc. Corporate Summary
Table 53. Endoceutics, Inc. Postmenopausal Vaginal Atrophy Drugs Product Offerings
Table 54. Endoceutics, Inc. Postmenopausal Vaginal Atrophy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Novo Nordisk A/S Corporate Summary
Table 56. Novo Nordisk A/S Postmenopausal Vaginal Atrophy Drugs Product Offerings
Table 57. Novo Nordisk A/S Postmenopausal Vaginal Atrophy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Pfizer Inc. Corporate Summary
Table 59. Pfizer Inc. Postmenopausal Vaginal Atrophy Drugs Product Offerings
Table 60. Pfizer Inc. Postmenopausal Vaginal Atrophy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Teva Pharmaceuticals Ltd. Corporate Summary
Table 62. Teva Pharmaceuticals Ltd. Postmenopausal Vaginal Atrophy Drugs Product Offerings
Table 63. Teva Pharmaceuticals Ltd. Postmenopausal Vaginal Atrophy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Therapeutics MD, Inc. Corporate Summary
Table 65. Therapeutics MD, Inc. Postmenopausal Vaginal Atrophy Drugs Product Offerings
Table 66. Therapeutics MD, Inc. Postmenopausal Vaginal Atrophy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Shionogi & Company Corporate Summary
Table 68. Shionogi & Company Postmenopausal Vaginal Atrophy Drugs Product Offerings
Table 69. Shionogi & Company Postmenopausal Vaginal Atrophy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Allergan plc Corporate Summary
Table 71. Allergan plc Postmenopausal Vaginal Atrophy Drugs Product Offerings
Table 72. Allergan plc Postmenopausal Vaginal Atrophy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Shionogi & Co. Ltd. Corporate Summary
Table 74. Shionogi & Co. Ltd. Postmenopausal Vaginal Atrophy Drugs Product Offerings
Table 75. Shionogi & Co. Ltd. Postmenopausal Vaginal Atrophy Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Postmenopausal Vaginal Atrophy Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 77. Global Postmenopausal Vaginal Atrophy Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Postmenopausal Vaginal Atrophy Drugs Production by Region, 2017-2022 (K Units)
Table 79. Global Postmenopausal Vaginal Atrophy Drugs Production by Region, 2023-2028 (K Units)
Table 80. Postmenopausal Vaginal Atrophy Drugs Market Opportunities & Trends in Global Market
Table 81. Postmenopausal Vaginal Atrophy Drugs Market Drivers in Global Market
Table 82. Postmenopausal Vaginal Atrophy Drugs Market Restraints in Global Market
Table 83. Postmenopausal Vaginal Atrophy Drugs Raw Materials
Table 84. Postmenopausal Vaginal Atrophy Drugs Raw Materials Suppliers in Global Market
Table 85. Typical Postmenopausal Vaginal Atrophy Drugs Downstream
Table 86. Postmenopausal Vaginal Atrophy Drugs Downstream Clients in Global Market
Table 87. Postmenopausal Vaginal Atrophy Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Postmenopausal Vaginal Atrophy Drugs Segment by Type
Figure 2. Postmenopausal Vaginal Atrophy Drugs Segment by Application
Figure 3. Global Postmenopausal Vaginal Atrophy Drugs Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Postmenopausal Vaginal Atrophy Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Postmenopausal Vaginal Atrophy Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Postmenopausal Vaginal Atrophy Drugs Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Postmenopausal Vaginal Atrophy Drugs Revenue in 2021
Figure 9. By Type - Global Postmenopausal Vaginal Atrophy Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Postmenopausal Vaginal Atrophy Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Postmenopausal Vaginal Atrophy Drugs Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Postmenopausal Vaginal Atrophy Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Postmenopausal Vaginal Atrophy Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Postmenopausal Vaginal Atrophy Drugs Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Postmenopausal Vaginal Atrophy Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Postmenopausal Vaginal Atrophy Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Postmenopausal Vaginal Atrophy Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Postmenopausal Vaginal Atrophy Drugs Sales Market Share, 2017-2028
Figure 19. US Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Postmenopausal Vaginal Atrophy Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Postmenopausal Vaginal Atrophy Drugs Sales Market Share, 2017-2028
Figure 24. Germany Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Postmenopausal Vaginal Atrophy Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Postmenopausal Vaginal Atrophy Drugs Sales Market Share, 2017-2028
Figure 33. China Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Postmenopausal Vaginal Atrophy Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Postmenopausal Vaginal Atrophy Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Postmenopausal Vaginal Atrophy Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Postmenopausal Vaginal Atrophy Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Postmenopausal Vaginal Atrophy Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Postmenopausal Vaginal Atrophy Drugs Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Postmenopausal Vaginal Atrophy Drugs by Region, 2020 VS 2027
Figure 50. Postmenopausal Vaginal Atrophy Drugs Industry Value Chain
Figure 51. Marketing Channels